CDK6 and neoplasm: Further in vivo and in vitro experiments demonstrated that miR-124, acting as a tumor suppressor, inhibited tumor cell growth by targeting cyclin-dependent kinase 6 (CDK6), which is a member of the family of serine-threonine kinases that promotes cell cycle progression.87